Skip to main content
Premium Trial:

Request an Annual Quote

Rubicon Genomics Starts SAB For Move Into Drug Development Services

NEW YORK, May 30-Rubicon Genomics said today that it was forming a scientific advisory board to oversee the expansion of OmniPlex, its DNA amplification system.


The company plans to develop and validate its technology for use in whole genome amplification and molecular haplotyping, applications useful in drug development.


The new scientific advisory board includes the University of Michigan's Michael Boehnke, Sensors for Medicine and Science's Anthony Czarnik and the University of Oklahoma's Bruce Roe.


Boehnke, a biostatistician, is director of the University of Michigan Center for Statistical Genetics  and the principal investigator in the Finland-United States Investigation of NIDDM Genetics Study.


Czarnik is chief scientific officer at Sensors for Medicine and Science, a company that is developing a new molecular detection technology. He was previously director of bio-organic chemistry at Parke-Davis and was a co-founder of Illumina.


Roe is director of the University of Oklahoma's Advanced Center for Genome Technology, where he lead a team involved in the Human Genome Project.


Rubicon, founded in 1998 as a spinoff from the University of Michigan, specializes in developing alternatives to PCR. It is based in Ann Arbor, Mich.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.